Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04081688
Title Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field